Publicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (34)

2022

  1. MICEmi: A method to identify cognitive endophenotypes of mental illnesses

    European Psychiatry, Vol. 65, Núm. 1

2020

  1. Childhood trauma and substance use underlying psychosis: a systematic review

    European Journal of Psychotraumatology, Vol. 11, Núm. 1

  2. Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia

    Frontiers in Psychology, Vol. 11

2019

  1. Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study.

    Journal of Affective Disorders, Vol. 257, pp. 31-37

2018

  1. Duration of active psychosis and functional outcomes in first-episode non-affective psychosis

    European Psychiatry, Vol. 52, pp. 29-37

2017

  1. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment

    Psychopharmacology, Vol. 234, Núm. 17, pp. 2563-2570

  2. Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study

    Journal of Affective Disorders, Vol. 215, pp. 156-162

  3. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 267, Núm. 4, pp. 315-323

2016

  1. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 7, pp. 619-628

2015

  1. Disability in bipolar i disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0

    Journal of Affective Disorders, Vol. 174, pp. 353-360

  2. Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors

    European Neuropsychopharmacology, Vol. 25, Núm. 12, pp. 2278-2288

2014

  1. Alzheimer's disease and cancer: Current epidemiological evidence for a mutual protection

    Neuroepidemiology

  2. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 90-94

  3. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: The first year is a critical period for development of cardiovascular risk factors

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 1, pp. 41-51

  4. Inverse and direct cancer comorbidity in people with central nervous system disorders: A meta-analysis of cancer incidence in 577,013 participants of 50 observational studies

    Psychotherapy and Psychosomatics, Vol. 83, Núm. 2, pp. 89-105

  5. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis

    Psychological Medicine, Vol. 44, Núm. 1, pp. 37-50

2013

  1. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study

    Schizophrenia Research, Vol. 150, Núm. 1, pp. 121-128

  2. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone

    Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625

  3. Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 44, pp. 162-167

  4. Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 43, pp. 23-28